We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$661M
AUM Growth
-$473M
Cap. Flow
-$486M
Cap. Flow %
-73.58%
Top 10 Hldgs %
6.77%
Holding
1,175
New
248
Increased
83
Reduced
484
Closed
358

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$3.58M
2
AZO icon
AutoZone
AZO
+$3.03M
3
HWM icon
Howmet Aerospace
HWM
+$2.87M
4
ANSS
Ansys
ANSS
+$2.84M
5
IT icon
Gartner
IT
+$2.66M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.61M
2
GM icon
General Motors
GM
+$6.29M
3
BG icon
Bunge Global
BG
+$5.38M
4
QCOM icon
Qualcomm
QCOM
+$5M
5
USFD icon
US Foods
USFD
+$4.97M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 20.5%
3 Financials 14.07%
4 Industrials 12.62%
5 Consumer Discretionary 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRSH icon
101
Freshworks
FRSH
$2.99B
$1.57M 0.24%
121,427
-36,145
-23% -$511K
ZIP icon
102
ZipRecruiter
ZIP
$346M
$1.57M 0.24%
95,088
-30,173
-24% -$526K
SBLK icon
103
Star Bulk Carriers
SBLK
$3.02B
$1.57M 0.24%
89,629
-107,339
-54% -$2.45M
SON icon
104
Sonoco
SON
$5.8B
$1.56M 0.24%
27,535
-26,563
-49% -$1.63M
IBP icon
105
Installed Building Products
IBP
$6.16B
$1.54M 0.23%
+19,056
New +$1.76M
PGNY icon
106
Progyny
PGNY
$2.47B
$1.54M 0.23%
+41,550
New +$1.56M
NVRO
107
DELISTED
NEVRO CORP.
NVRO
$1.54M 0.23%
32,987
-4,855
-13% -$225K
BLMN icon
108
Bloomin' Brands
BLMN
$731M
$1.53M 0.23%
83,518
-90,762
-52% -$1.8M
RCUS icon
109
Arcus Biosciences
RCUS
$3.5B
$1.53M 0.23%
58,528
+30,910
+112% +$817K
V icon
110
Visa
V
$689B
$1.53M 0.23%
+8,615
New +$1.75M
EDIT icon
111
Editas Medicine
EDIT
$411M
$1.53M 0.23%
124,758
+37,793
+43% +$589K
NARI
112
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.53M 0.23%
21,027
+5,122
+32% +$381K
SPOT icon
113
Spotify
SPOT
$102B
$1.52M 0.23%
17,652
-11,246
-39% -$1.2M
HAS icon
114
Hasbro
HAS
$12.8B
$1.52M 0.23%
+22,571
New +$1.78M
DXCM icon
115
DexCom
DXCM
$28.3B
$1.52M 0.23%
+18,853
New +$1.6M
ARRY icon
116
Array Technologies
ARRY
$848M
$1.52M 0.23%
+91,457
New +$1.58M
SUPN icon
117
Supernus Pharmaceuticals
SUPN
$2.73B
$1.51M 0.23%
44,634
-21,309
-32% -$693K
SNV
118
DELISTED
Synovus
SNV
$1.5M 0.23%
39,989
-54,019
-57% -$2.14M
MTDR icon
119
Matador Resources
MTDR
$5.86B
$1.5M 0.23%
30,637
-16,062
-34% -$867K
CRSP icon
120
CRISPR Therapeutics
CRSP
$4.6B
$1.5M 0.23%
22,920
-3,818
-14% -$277K
W icon
121
Wayfair
W
$12.5B
$1.49M 0.23%
45,876
-20,159
-31% -$1.07M
CM icon
122
Canadian Imperial Bank of Commerce
CM
$108B
$1.49M 0.23%
34,031
-11,235
-25% -$548K
TRN icon
123
Trinity Industries
TRN
$2.95B
$1.49M 0.23%
69,701
-44,371
-39% -$1.09M
FELE icon
124
Franklin Electric
FELE
$4.66B
$1.49M 0.22%
18,185
-9,072
-33% -$773K
HES
125
DELISTED
Hess
HES
$1.48M 0.22%
13,587
-28,977
-68% -$3.21M

Similar funds

PDT Partners's Q3 2022 Portfolio in Review

As of Q3 2022, PDT Partners held 1,175 positions worth $661M, down 42% from $1.13B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

PDT Partners withdrew a net $486M in Q3 2022, closing 358 positions and reducing 484 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $7.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, PDT Partners opened a new position in Coupang worth $3.45M.

  • PDT Partners's largest Q3 2022 buy was Coupang: 207,142 shares worth $3.45M.
  • PDT Partners added most to AutoZone in Q3 2022, an estimated $3.03M increase.
  • PDT Partners's biggest Q3 2022 reduction was General Motors, cutting an estimated $6.29M.
  • PDT Partners fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $7.61M.
  • PDT Partners's ten largest holdings make up 6.8% of its $661M portfolio in Q3 2022.
  • PDT Partners opened 248 new positions and closed 358 in Q3 2022.
  • PDT Partners's portfolio value fell 42% quarter-over-quarter to $661M.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.